These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2096108)

  • 1. Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians.
    Milon D; Allain H; Reymann JM; Morel G; Sabouraud O; Van den Driessche J
    Fundam Clin Pharmacol; 1990; 4(6):695-705. PubMed ID: 2096108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heptaminol chlorhydrate: new data].
    Pourrias B
    Ann Pharm Fr; 1991; 49(3):127-38. PubMed ID: 1929117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects.
    Micieli G; Martignoni E; Cavallini A; Pacchetti C; Rossi F; Horowski R; Nappi G
    Funct Neurol; 1996; 11(6):317-25. PubMed ID: 9074912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of octreotide on experimental orthostatic neurogenic hypotension].
    Verwaerde P; Bordet R; Portolan G; Tran MA; Marques MA; Montastruc JL; Sénard JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1097-1101. PubMed ID: 8949386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine-induced orthostatic hypotension.
    Van Loon GR
    Clin Invest Med; 1979; 2(4):131-4. PubMed ID: 549762
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France.
    Pathak A; Raoul V; Montastruc JL; Senard JM
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):471-4. PubMed ID: 15991040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension.
    Senard JM; Rascol O; Rascol A; Montastruc JL
    Fundam Clin Pharmacol; 1993; 7(8):465-70. PubMed ID: 8294084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine.
    Lacomblez L; Bensimon G; Isnard F; Diquet B; Lecrubier Y; Puech AJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):241-51. PubMed ID: 2920499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
    Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
    Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of Korodin Herz-Kreislauf-Tropfen as add-on treatment in older patients with orthostatic hypotension.
    Kroll M; Ring C; Gaus W; Hempel B
    Phytomedicine; 2005 Jun; 12(6-7):395-402. PubMed ID: 16008114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
    Fouad-Tarazi FM; Okabe M; Goren H
    Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-human primate model for investigating drug-induced risk of orthostatic hypotension and sympathetic dysfunction: Preclinical correlate to a clinical test.
    Bhatt S; Foote S; Smith A; Butler P; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2015; 73():49-55. PubMed ID: 25837852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension.
    Belz GG; Butzer R; Gaus W; Loew D
    Phytomedicine; 2002 Oct; 9(7):581-8. PubMed ID: 12487321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.
    Senard JM; Valet P; Durrieu G; Berlan M; Tran MA; Montastruc JL; Rascol A; Montastruc P
    Eur J Clin Invest; 1990 Dec; 20(6):613-9. PubMed ID: 1964123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure effects of apomorphine and domperidone in parkinsonism.
    Pollak P; Mallaret M; Gaio JM; Hommel M; Perret J
    Adv Neurol; 1987; 45():263-6. PubMed ID: 3548261
    [No Abstract]   [Full Text] [Related]  

  • 16. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
    Hauser RA; Isaacson S; Lisk JP; Hewitt LA; Rowse G
    Mov Disord; 2015 Apr; 30(5):646-54. PubMed ID: 25487613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium supplementation in the treatment of idiopathic postural hypotension.
    Heseltine D; Thomas T; Wilkinson R; James OF; Potter JF
    Age Ageing; 1990 Nov; 19(6):409-14. PubMed ID: 2285009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.
    Biaggioni I; Freeman R; Mathias CJ; Low P; Hewitt LA; Kaufmann H;
    Hypertension; 2015 Jan; 65(1):101-7. PubMed ID: 25350981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.
    de Mey C; Michel MC; McEwen J; Moreland T
    Eur Urol; 1998; 33(5):481-8. PubMed ID: 9643668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of Thomasin (etilefrin) in hypotensive and/or orthostatic circulatory disorders in comparison with pholedrine and placebo (double-blind study)].
    Gruber G
    Z Arztl Fortbild (Jena); 1982 Feb; 76(4):149-53. PubMed ID: 6125062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.